ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
HA-1 TCR T-cell Immunotherapy for Acute Leukemia | Fred Hutchinson Cancer Research Center / Marie Bleakley, M.D., Ph.D. | Bio-Therapeutic Impact Award | 2014 | Washington |
Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML | Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD | 'A' Award Grants | 2012 | Washington |
Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells | Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD | Young Investigator Grants | 2014 | Washington |
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia | Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD | Young Investigator Grants | 2014 | Washington |
Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma | Seattle Children’s Hospital / Shireen Ganapathi, MD | Young Investigator Grants | 2021 | Washington |
Aberrant DNA methylation in Ewing sarcoma. | Fred Hutchinson Cancer Research Center / Scott Borinstein | Young Investigator Grants | 2009 | Washington |
The Role of DNA Methylation in Pediatric Cancer | Fred Hutchinson Cancer Research Center / Scott Diede | Young Investigator Grants | 2010 | Washington |
Restoring RUNX1 Levels in FPD/AML | University of Washington, Seattle / Marshall Horwitz, MD/PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2016 | Washington |
Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children | Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD/PhD | Reach Grants | 2018 | Washington |
Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents | Seattle Children’s Hospital and Regional Medical Center / Julie Park, MD | Phase I/II Infrastructure Grants | 2006 | Washington |